Cited by 27Telemedicine and Telehealth ImplementationParkinson's Disease Mechanisms and TreatmentsHealthcare Systems and Technology

Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial

Open access
Achey, Meredith A, Beck, Christopher A, Beran, Denise B, Boyd, Cynthia M, Schmidt, Peter N, Willis, Allison W, Riggare, Sara S, Simone, Richard B +2 more·2014·Trials

Abstract

BACKGROUND: Interest in improving care for the growing number of individuals with chronic conditions is rising. However, access to care is limited by distance, disability, and distribution of doctors. Small-scale studies in Parkinson disease, a prototypical chronic condition, have suggested that delivering care using video house calls is feasible, offers similar clinical outcomes to in-person care, and reduces travel burden. METHODS/DESIGN: We are conducting a randomized comparative effectiveness study (Connect.Parkinson) comparing usual care in the community to usual care augmented by virtual house calls with a Parkinson disease specialist. Recruitment is completed centrally using online advertisements and emails and by contacting physicians, support groups, and allied health professionals. Efforts target areas with a high proportion of individuals not receiving care from neurologists. Approximately 200 individuals with Parkinson disease and their care partners will be enrolled at 20 centers throughout the United States and followed for one year. Participants receive educational materials, then are randomized in a 1:1 ratio to continue their usual care (control arm) or usual care and specialty care delivered virtually (intervention arm). Care partners are surveyed about their time and travel burden and their perceived caregiver burden. Participants are evaluated via electronic survey forms and videoconferencing with a blinded independent rater at baseline and at 12 months. All study activities are completed remotely.The primary outcomes are: (1) feasibility, as measured by the proportion of visits completed, and (2) quality of life, as measured by the 39-item Parkinson's Disease Questionnaire. Secondary outcomes include measures of clinical benefit, quality of care, time and travel burden, and caregiver burden. DISCUSSION: Connect.Parkinson will evaluate the feasibility and effectiveness of using technology to deliver care into the homes of individuals with Parkinson disease. The trial may serve as a model for increasing access and delivering patient-centered care at home for individuals with chronic conditions. TRIAL REGISTRATION: This trial was registered on clinicaltrials.gov on January 8, 2014 [NCT02038959].

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1745-6215-15-465

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Large randomized-controlled trials of virtual house calls for PD are underway.

    “large randomized-controlled trials (RCT) are underway (Achey et al., 2014”

    From Remote delivery of psychological interventions for Parkinson's disease. (2018) · cites this paper as Achey et al., 2014

    The Methods (Sample size; page unavailable) specify a randomized trial of 200 Parkinson disease patients, and Trial status says it was recruiting participants. This supports a substantial virtual-house-call trial underway, but the paper documents one such trial, not the plural 'trials' claimed. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 123 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [116]State Coverage for Telehealth Services: National Conference of State Legislatures. [ http://www.ncsl.org/research/health/state-coverage-for-telehealth-services.aspx]
  2. [117]Centers for Medicare and Medicaid Services Chapter 15 - covered medical and other health services Medicare Benefit Policy Manual 2013

Cited by

Sorted by citations

Authors
Achey, M. A., Beck, C. A., Beran, D. B., Boyd, C. M., Schmidt, P. N., Willis, A. W., Riggare, S. S., Simone, R. B., Biglan, K. M., & Dorsey, E. R.
Affiliations
  • University of Rochester Medicine (US)
  • National Parkinson's Foundation (US)
  • Johns Hopkins University (US)
  • University of Pennsylvania (US)
  • Karolinska Institutet (SE)
Corresponding author
Boyd, Cynthia M
Venue
Trials
Published
2014-11-27
Volume
15
Issue
1
Pages
465-465
ISSN
1745-6215 (ISSN-L)
OpenAlex
W2156371951
Cited by
27
References
123
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 3
FWCI
3.32
Type
journal article
Language
en
Open access
Locations
  • Trials (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Michael J. Fox Foundation for Parkinson's Research
  • Robert Wood Johnson Foundation
  • John A. Hartford Foundation
  • Hartford Foundation for Public Giving
  • National Parkinson Foundation
  • Center for Health Care Strategies
  • Amgen
  • Commonwealth Foundation
  • Biogen
  • Patient-Centered Outcomes Research Institute (AD‐12‐11‐4701)
  • Teva Pharmaceutical Industries
  • University of Rochester (UL1TR000042)
  • Boston Scientific Corporation
  • Starr Foundation
  • Davis Phinney Foundation
  • Amarin Corporation
  • Georgia Clinical and Translational Science Alliance
  • Verizon Foundation
  • H. Lundbeck A/S
  • National Institutes of Health (UL1TR000042, TR000042)
  • Agency for Healthcare Research and Quality
  • Parkinsonfonden
  • Avid Radiopharmaceuticals
  • National Institute of Neurological Disorders and Stroke (K23NS081087)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Healthcare Systems and Technology
Keywords
Parkinson's disease, telemedicine, videoconferencing, health care access, care partners, caregiver burden, travel burden, quality of life, Parkinson's Disease Questionnaire, chronic disease, home care
MeSH terms
Clinical Protocols, Delivery of Health Care, Feasibility Studies, Health Services Accessibility, House Calls, Humans, Parkinson Disease, Quality of Life, Surveys and Questionnaires, Research Design, Time Factors, Transportation, United States, Treatment Outcome, Caregivers, Cost of Illness, Remote Consultation, Videoconferencing, Comparative Effectiveness Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review